A boronic acid conjugation integrates antitumor drugs into albumin-binding prodrugs-based nanoparticles with robust efficiency for cancer therapy
Crossref DOI link: https://doi.org/10.1007/s12274-023-5474-8
Published Online: 2023-02-27
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ban, Weiyue
Luo, Qiuhua
Yan, Chengda
Fan, Xiaoying
Zhu, Guorui
Cheng, Maosheng
He, Zhonggui
Sun, Mengchi
Sun, Jin
Text and Data Mining valid from 2023-02-27
Version of Record valid from 2023-02-27
Article History
Received: 23 November 2022
Revised: 27 December 2022
Accepted: 1 January 2023
First Online: 27 February 2023